Business
Blueberries Medical Announces C$1 Million Non-Brokered Private Placement
TORONTO, March 25, 2025 (GLOBE NEWSWIRE) -- Blueberries Medical Corp. (CSE: BBM) (OTC: BBRRF) (FRA: 1OA) (the "Company" or "Blueberries"), a Latin American licensed producer of medicinal cannabis and cannabis-derived products, is pleased to announce a non-brokered private placement consisting of the sale of 96,064,935 common shares ("Common Shares") at a price of C$0.011 per Common Share for aggregate gross proceeds of approximately C$1.05 million (or approximately US$740,000) (the "Offering").
About this update from Blueberries Medical Corp.
[{"type":"image","alt":"Blueberries Medical Corp.","displaySize":"","headline":null,"caption":"Blueberries Medical Corp.","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":89,"url":"https://media.zenfs.com/en/globenewswire.com/81ebed1004c667d8cb2aed08ca73f505"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/SCfaE3PjJZhqFEiE_9yANQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTEyNTtjZj13ZWJw/https://media.zenfs.com/en/globenewswire.com/81ebed1004c667d8cb2aed08ca73f505","width":300,"height":89}},"lazy":false},{"type":"text","content":"TORONTO, March 25, 2025 (GLOBE NEWSWIRE) -- Blueberries Medical Corp. (CSE: BBM) (OTC: BBRRF) (FRA: 1OA) (the "Company" or "Blueberries"), a Latin American licensed producer of medicinal cannabis and cannabis-derived products, is pleased to announce a non-brokered private placement consisting of the sale of 96,064,935 common shares ("Common Shares") at a price of C$0.011 per Common Share for aggregate gross proceeds of approximately C$1.05 million (or approximately US$740,000) (the "Offering"). The net proceeds from the sale of the Common Shares are expected to fund and expand operations, for general corporate and working capital purposes. The Offering is expected to close on or about March 25, 2025.","length":749,"tagName":"p"},{"type":"text","content":"It is expected that the Offering will be led by Terraflos Inc. ("Terraflos"), a company with operations throughout Latin America founded and controlled by Facundo Garreton ("Mr. Garreton"), who serves as the Chairman, CEO, and a director of Blueberries. Terraflos is currently exploring various prospects in Argentina, Mexico, and Brazil and aims to expand its operations into those markets in the short term. The company's objective is to satisfy food and medicine needs in the near future using non-conventional methods, without exploiting natural resources as is common in current methodologies. In addition, Guillermo Rodriguez, a director of the Company, is also expected to participate in the Offering.","length":732,"tagName":"p"},{"type":"text","content":"Early Warning Disclosure ","length":24,"tagName":"p"},{"type":"text","content":"Immediately prior to the Offering Mr. Garreton, directly and through Terraflos, owned 242,346,666 Common Shares, options exercisable into 5,049,500 Common Sh...